Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis

• Register: ClinicalTrials.gov
• Last refreshed on: 8 March 2021
• Main ID: NCT04579939
• Date of registration: 29/09/2020
• Prospective Registration: Yes
• Primary sponsor: Mayo Clinic
• Public title: Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis
• Scientific title: Oral Glucose Tolerance Testing Using Candy: A Sweet Solution to Improve Screening Compliance in Cystic Fibrosis
• Date of first enrolment: February 25, 2021
• Target sample size: 10
• Recruitment status: Recruiting
• URL: https://clinicaltrials.gov/show/NCT04579939
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

United States

Contacts

• Name: Ana Creo, MD
• Affiliation: Mayo Clinic

• Name: Ana Creo, MD

Key inclusion & exclusion criteria

Inclusion Criteria:

- Males and Females ages 10-21 years.

- Cystic Fibrosis (CF) must be diagnosed.

- Ability to sign informed consent if they are 18 years or older.

- Written parental permission if age 10-17 years old.

Exclusion criteria:

- Active CF flare as determined by the primary CF team .

- Use of steroids.

- Inability to tolerate oral feedings.

- Prior intestinal surgery.

- Concern for allergy or intolerance to dextrose, fructose, or corn derivatives.



Age minimum: 10 Years
Age maximum: 21 Years
Gender: All

Health Condition(s) or Problem(s) studied

Cystic Fibrosis

Intervention(s)

Diagnostic Test: Candy Glucose Tolerance Test

Primary Outcome(s)

Glycemic Response [Time Frame: Baseline, Day 1]

Secondary Outcome(s)

Patient and Parent Satisfaction [Time Frame: Day 2]

Secondary ID(s)

20-002446

Source(s) of Monetary Support

Please refer to primary and secondary sponsors